Literature DB >> 19192432

Effective agents in treating bipolar depression.

Andrew A Nierenberg1.   

Abstract

Individuals with bipolar disorder may spend about half of their time euthymic, but recurring mood episodes are common and are predominated by depressive symptoms. Despite the prevalence of depression in bipolar disorder, evidence suggests that antidepressants are not likely to benefit most patients. Lithium has long been the first-line treatment for bipolar disorder, but it is not the most effective agent for treating bipolar depression. This activity reviews multiple pharmacologic options that should be considered by clinicians treating bipolar disorder. Copyright 2008 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19192432     DOI: 10.4088/jcp.1008e29

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockΔ19 mouse model of mania.

Authors:  Laurent Coque; Shibani Mukherjee; Jun-Li Cao; Sade Spencer; Marian Marvin; Edgardo Falcon; Michelle M Sidor; Shari G Birnbaum; Ami Graham; Rachael L Neve; Elizabeth Gordon; Angela R Ozburn; Matthew S Goldberg; Ming-Hu Han; Donald C Cooper; Colleen A McClung
Journal:  Neuropsychopharmacology       Date:  2011-03-23       Impact factor: 7.853

2.  Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion.

Authors:  Qifei Zou; Ying Hou; Feng Shen; Yizheng Wang
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.